On March 13,China's National Medical Products Administration(NMPA)sent shock waves across the international medical technology sector by granting the world's first approval for an invasive,commercial-use brain...On March 13,China's National Medical Products Administration(NMPA)sent shock waves across the international medical technology sector by granting the world's first approval for an invasive,commercial-use brain-computer interface(BCI)system.Developed by Neuracle Medical Technology(Shanghai)Co.Ltd.,the system restores hand movement for people with severe paralysis.The approval marks the beginning of a new era in which BCI technologies,long confined to laboratories and science fiction,break through into clinical medicine and begin treating medical issues at scale.展开更多
文摘On March 13,China's National Medical Products Administration(NMPA)sent shock waves across the international medical technology sector by granting the world's first approval for an invasive,commercial-use brain-computer interface(BCI)system.Developed by Neuracle Medical Technology(Shanghai)Co.Ltd.,the system restores hand movement for people with severe paralysis.The approval marks the beginning of a new era in which BCI technologies,long confined to laboratories and science fiction,break through into clinical medicine and begin treating medical issues at scale.
